跳至主要内容
临床试验/CTRI/2022/04/041690
CTRI/2022/04/041690已完成未知

Effectiveness and Tolerability of Oral Iron Supplementation in Pregnant Womenâ?? A Retrospective, Real-World Evidence Study.

Sun Pharma Laboratories Limited0 个研究点目标入组 195 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
195

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • (1.) Pregnant women with age between 20 and 40 years (2.) Subjects who received iron supplements in the form of Speedral capsule for greater than equal to 3 months during pregnancy at period of gestation greater than equal to 12 weeks (3.) Singleton pregnancy

排除标准

  • 1. Subjects with recent history of blood transfusion
  • 2. Subjects with malabsorptive and restrictive bariatric surgery
  • 3. Subjects with inflammatory bowel disease, irritable bowel syndrome, celiac disease,
  • atrophic gastritis, Helicobacter pylori or any active infection
  • 4. Subjects receiving any iron supplementation other than Speedral Capsule
  • 5. Subjects with Folate or Vitamin B12 deficiency anemia, sideroblastic anemia,
  • thalassemia, sickle cell anemia, aplastic anemia, hemolytic anemia, and anemia of
  • chronic disease.

研究者

相似试验